|
|||||||
| 23. | CASH FLOW INFORMATION | ||||||
| CONSOLIDATED | THE COMPANY | ||||||
| 2007 | 2006 | 2007 | 2006 | ||||
| R million | R million | R million | R million | ||||
| 23.1 Adjustments | |||||||
| Depreciation, amortisation of goodwill and trade marks | 237 | 302 | | | |||
| Movement in provisions | (58) | 65 | | | |||
| Interest received | (334) | (341) | | | |||
| Finance cost | 30 | 29 | | | |||
| Dividends received | (156) | (410) | (3 358) | (4 191) | |||
| Capital surplus on the sale of investments | (7) | (3 161) | | | |||
| Net impairment of assets | | (3) | | | |||
| Share scheme cost | 18 | 18 | | | |||
| Negative goodwill | (44) | | | | |||
| Exchange rate gain/(loss) on foreign cash | 622 | (85) | | | |||
| Other | 1 | (2) | | | |||
| 309 | (3 588) | (3 358) | (4 191) | ||||
| 23.2 Decrease/(increase) in working capital | |||||||
| Decrease/(increase) in inventories and biological agricultural | |||||||
| assets | (180) | (139) | | | |||
| Decrease/(increase) in trade and other receivables | (109) | (121) | (1) | (4) | |||
| Increase/(decrease) in trade and other payables | 86 | 252 | 3 | 2 | |||
| Net movement in derivative instruments | 33 | (33) | | | |||
| (170) | (41) | 2 | (2) | ||||
| 23.3 Reconciliation of dividends received | |||||||
| Receivable at the beginning of the year | | 129 | | | |||
| Per income statement | 156 | 410 | 3 358 | 4 191 | |||
| Dividends from associated companies set off against | |||||||
| investments | 2 748 | 3 349 | |||||
| Receivable at the end of the year | (168) | | | | |||
| Cash received | 2 736 | 3 888 | 3 358 | 4 191 | |||
| 23.4 Reconciliation of taxation paid with the amount | |||||||
| disclosed in the income statement | |||||||
| Paid in advance at the beginning of the year | 67 | 60 | | | |||
| Unpaid at the beginning of the year | (473) | (69) | | | |||
| Per income statement | (360) | (854) | | | |||
| normal income | (339) | (491) | | | |||
| capital gain | | (350) | | | |||
| STC | (21) | (13) | | | |||
| Medi-Clinic | | 91 | | | |||
| Business acquired | | (3) | | | |||
| Unpaid at the end of the year | 104 | 473 | | | |||
| Paid in advance at the end of the year | (14) | (67) | | | |||
| Cash paid | (676) | (369) | | | |||
| 23.5 Reconciliation of dividends paid | |||||||
| Per statements of changes in equity | (3 748) | (4 525) | (3 782) | (4 860) | |||
| Paid by subsidiary companies to minority | (65) | (151) | |||||
| Cash paid | (3 813) | (4 676) | (3 782) | (4 860) | |||